Anudishi Tyagi

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

B7-H3 (CD276): an actionable therapeutic target and prognostic biomarker across human malignancies.

B7-H3 (CD276): an actionable therapeutic target and prognostic biomarker across human malignancies.

Journal: Frontiers in immunology
Published: April 16, 2026

RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia.

RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 04, 2025

Donor-Derived Vγ9Vδ2 T Cells for Acute Myeloid Leukemia: A Promising "Off-the-Shelf" Immunotherapy Approach.

Donor-Derived Vγ9Vδ2 T Cells for Acute Myeloid Leukemia: A Promising "Off-the-Shelf" Immunotherapy Approach.

Journal: Cancers
Published: June 20, 2025

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer.

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer.

Journal: NPJ breast cancer
Published: April 24, 2025

FT538, iPSC-derived NK cells, enhance AML cell killing when combined with chemotherapy.

FT538, iPSC-derived NK cells, enhance AML cell killing when combined with chemotherapy.

Journal: Journal of cellular and molecular medicine
Published: August 20, 2024

TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.

TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.

Journal: Leukemia
Published: August 17, 2023

Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML.

Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML.

Journal: Blood
Published: November 03, 2021

Evaluation of Vascular Endothelial Growth Factor (VEGF) and Thrombospondin-1 as Biomarkers of Metronomic Chemotherapy in Progressive Pediatric Solid Malignancies.

Evaluation of Vascular Endothelial Growth Factor (VEGF) and Thrombospondin-1 as Biomarkers of Metronomic Chemotherapy in Progressive Pediatric Solid Malignancies.

Journal: Indian pediatrics
Published: March 30, 2020

Dysregulation of miRNA expression and their prognostic significance in paediatric cytogenetically normal acute myeloid leukaemia.

Dysregulation of miRNA expression and their prognostic significance in paediatric cytogenetically normal acute myeloid leukaemia.

Journal: British journal of haematology
Published: September 20, 2019

Genetic Landscape of Mitochondrial Regulatory Region in Pediatric Acute Myeloid Leukemia: Changes from Diagnosis to Relapse.

Genetic Landscape of Mitochondrial Regulatory Region in Pediatric Acute Myeloid Leukemia: Changes from Diagnosis to Relapse.

Journal: Journal of pediatric genetics
Published: May 16, 2019

Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia.

Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia.

Journal: International journal of hematology
Published: December 17, 2018

Prognostic impact of mitochondrial DNA D-loop variations in pediatric acute myeloid leukemia.

Prognostic impact of mitochondrial DNA D-loop variations in pediatric acute myeloid leukemia.

Journal: Oncotarget
Published: October 30, 2018
Showing 1-12 of 16

Last Updated: 09/26/2026